Related Experiment Video

Updated: Jul 7, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

ZM336372, a Raf-1 activator, causes suppression of proliferation in a human hepatocellular carcinoma cell line

Dustin Deming1, Peter Geiger, Herbert Chen

  • 1Department of Medicine, University of Wisconsin, K4/528, Madison, WI 53792, USA.

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|February 27, 2008
PubMed

Insights

The Raf-1 activating agent ZM336372 inhibits hepatocellular carcinoma (HCC) cell growth, similar to neuroendocrine tumors (NETs). This agent suppresses hormone secretion and up-regulates cell cycle inhibitors in HCC cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Hepatocellular carcinoma (HCC) shares similarities with neuroendocrine tumors (NETs), including responses to extracellular signal-regulated kinase (ERK) pathway activation.
  • Both NET and HepG2 (HCC) cells exhibit growth inhibition upon ERK activation.
  • ZM336372, a Raf-1 activating agent, previously demonstrated growth inhibition and hormone secretion suppression in a NET cell line.

Purpose of the Study:

  • To investigate the anti-proliferative effects of ZM336372 on the human hepatocellular carcinoma (HepG2) cell line.
  • To determine if ZM336372 elicits similar responses in HCC cells as observed in NET cells, specifically regarding proliferation and pathway activation.

Main Methods:

  • HepG2 cells were treated with varying doses of ZM336372 or a solvent control (dimethyl sulfoxide).
  • Cell proliferation was assessed using the 3,4-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
  • Western blot analysis was employed to evaluate the activation of the Raf-1/mitogen-activated protein kinase kinase/ERK pathway, chromogranin A production, and p21CIP1 levels.

Main Results:

  • ZM336372 induced dose-dependent growth inhibition in HepG2 cells.
  • Treatment with ZM336372 resulted in the activation of the ERK pathway, indicated by increased phosphorylation.
  • Chromogranin A secretion was suppressed, and p21CIP1 levels were dose-dependently upregulated following ZM336372 treatment.

Conclusions:

  • ZM336372 effectively inhibits proliferation in a human hepatocellular carcinoma cell line.
  • The observed effects of ZM336372 on HCC cells, including growth inhibition, suppressed hormone secretion, and cell cycle inhibitor upregulation, mirror those seen in neuroendocrine tumors.
  • These findings suggest a potential therapeutic role for Raf-1 activating agents in treating hepatocellular carcinoma.

More Related Videos

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...